Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Advertising Regulation Wiki? Industry Wants Authoritative But Frequently Updated FDA Guidance (And/Or Regs) On Internet Drug Promotion

Executive Summary

It's up to FDA now to outline a "how-to" for drug makers when it comes to using the Internet and social media for drug promotion - with guidance, regulations or both. But drug makers made evident in comments on the agency's meeting last fall that FDA also must determine how to account for changing technologies

You may also be interested in...



FDA's Internet Promotion Guidance: One Down By Year-End; Four More To Go?

DDMAC is nearing completion of the first in what is expected to be a series of guidance documents pertaining to appropriate drug promotion on the Internet and with social media tools.

FDA's Internet Promotion Guidance: One Down By Year-End; Four More To Go?

DDMAC is nearing completion of the first in what is expected to be a series of guidance documents pertaining to appropriate drug promotion on the Internet and with social media tools.

Tysabri Webcast Citation May Signal That FDA Could Treat All Social Media Interactions As Promotional; Biogen's PML Strategy Also Takes A Hit

FDA appears to be gearing up to treat social media interactions as promotional even when they are aimed solely at informing physicians

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS052039

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel